Cancer With Personalized Testing Suppliers Serving Usa Kansas

MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...

We are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as a liquid biopsy. ...

Incorporated in PA in 2011, our MISSION is to translate our circulating cell-free DNA (cfDNA) in urine technology into improved cancer screening and management by liquid biopsy towards our VISION of decreased global cancer mortality. Our proprietary ...

Meda Biotech, LLC was founded in 2003 on the strength of a conviction that a new concept, HYBRID-NANOENGINEERINGTM, could solve insolubility problems and have real therapeutic value for patients. That belief gave birth to a process of continual ...

Sherlock Biosciences is dedicated to providing global access to the simplest and most accurate tests that empower individuals to control their own healthcare. Through its Engineering Biology platforms, the company is developing applications of ...

miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management ...

Polymedco is dedicated to enhancing early detection of life-threatening diseases as healthcare challenges intensify due to rising chronic disease rates, an aging population, and soaring medical costs. The company collaborates with healthcare ...

NeraCare develops and commercializes molecular diagnostic tests for patients with skin cancer. The tests provide actionable, tumor-specific information for each individual patient. The information is used to make improved treatment decisions, i.e. ...

20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...

We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high ...

Cellanyx is a growth stage emerging biotech advancing proprietary phenotypic (appearance and dynamics) biomarker tests based on Machine Vision and AI-driven analysis of live single tumor cells to improve risk-stratification and shared clinical ...

Getting ahead of cancer is crucial no matter where people are in their cancer journey. From earlier cancer detection to treatment guidance and monitoring, we are helping people get the answers they need to make more informed decisions across the ...

Time Medical (TM) is a leader in the medical diagnostic imaging industry with innovative and disruptive technology. TM develops advanced medical imaging systems including MRI, DR, and CT, as well as cost-effective solutions for emerging global ...

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company formed to commercialize a new modality in cancer screening and diagnosis called opto-acoustic imaging. A strong, experienced management team and nationally ...

Takara Bio companies provide kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, DSS Takara Bio India Private Ltd. is part of a company that holds ...

OTraces, Inc. has built, and extensively filed patents protection on, an early tumor detection and cancer screening software technology. Technology uses well-known math- and physics-based A-I methods including those used in advanced satellite ...

Alfresa Pharma develops, manufactures, and sells diagnostic reagents and equipments used in hospital laboratories and group medical examinations, with the mission of “delivering unprecedented new in vitro diagnostics.” We have applied our original ...

Anchor Molecular is a life science diagnostics company specializing in the development of best-in-class quality controls, reference materials, and reagents for liquid biopsy assays. We focus on liquid biopsy cancer diagnostic test based on cell-free ...

Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, ...

Altis Biosystems’ mission is to develop, manufacture, and sell innovative services and research tools to reduce costs and accelerate drug development with in vitro platforms that more accurately reflect native human biology. Altis Biosystems is a ...